Hyperpigmentation – Science

Hyperpigmentation – Science

Study summaries

Vitamin C

In a 2004 study, Mexican researchers tested a 5% ascorbic acid lotion against a 4% hydroquinone lotion in people with melasma. Both lotions markedly lightened the darker areas of the skin. Hydroquinone worked slightly better and gave results in one month while it took three months for the vitamin C lotion to lighten the skin. On the other hand, only one of the 16 patients complained of side effects from the vitamin C lotion as compared to 11 out of 16 for the hydroquinone lotion.

A Japanese study tested whether a fat-soluble form of vitamin C (tetra-isopalmitoyl ascorbic acid) can prevent UV-induced darkening of the skin. They exposed the forearms of the participants to UV radiation (1.5 times the amount it takes to cause a minor sunburn) and applied either a 3% vitamin C or control lotion immediately after the exposure. The vitamin C treated site showed about 13% less darkening than the control site.

Another Japanese study demonstrated 10% magnesium L-ascorbyl-2-phosphate (MAP) produced good or moderate lightening of melasma and liver spots in 19 out of 34 participants.

A 2013 study showed that silicone gel with vitamin C somewhat improved healing of surgical scars; the scars treated with the vitamin C gel showed less hyperpigmentation and color difference from the surrounding skin.

A Korean study showed that a superficial chemical peel combining alpha-hydroxy acid and vitamin C (as ascorbic acid) reduced hyperpigmentation in melasma patients. Unfortunately, I couldn’t find out the concentration of vitamin C. The study looked at this product from Korea.

Herndon et al. showed the combination of 30% vitamin C (as tetrahexyldecyl ascorbate) and 0.5% retinol lotion reduced hyperpigmentation roughly 10% in 12 weeks.

In 2009, Hwang et al. showed that 25% vitamin C (as ascorbic acid) lotion reduced melasma in 16 weeks. I don’t have access to the full-text version of this paper and can’t share with you how much things improved.


In 2013, Journal of Drugs in Dermatology published a paper testing two concentrations of retinol, 0.5% and 1%. The cream with 1% retinol showed good results in reducing signs of aging and hyperpigmentation, but people complained about the side-effects. The 0.5% retinol cream showed modest improvements in skin aging and hyperpigmentation but caused only minor side-effects. Products used in the study: https://www.skinstore.com/p-9841-retriderm-vitamin-a-serum-ultra.aspx

Another study tested the efficacy of 0.1% retinol on photodamage and skin aging. The participants applied 0.1% retinol moisturizer (active treatment) on one side of the face and an identical moisturizer without retinol on the other side. After eight weeks, the side treated with the retinol moisturizer showed about 50% better improvement in hyperpigmentation, wrinkles, fine lines, and overall photodamage.

Kikuchi et al. tested a 0.075% retinol cream and a placebo cream in a split-face study on middle-aged Japanese women. The results showed a reduction in wrinkles and hyperpigmentation in the retinol-treated side as compared to the placebo-treated side. The retinol-treated side also showed slightly more redness and scaling, but these disappeared during the study.

Vitamin B3

A study on Japanese women showed that 5% nicotinamide moisturizer reduced hyperpigmentation by nearly 25% vs. 15% reduction with a placebo moisturizer.

A large study of 246 Indian women showed a significant reduction in hyperpigmentation with a moisturizer containing 4% niacinamide, 0.5% panthenol, 0.5% vitamin E (as tocopheryl acetate), sunscreen, and glycerin. The moisturizer also improved skin tone and texture and lightened the skin.

Another large study showed that the combination of 4% niacinamide and 2% N-acetyl glucosamine (NAG) with SPF 15 was more effective than an SPF 15 sunscreen alone in reducing hyperpigmentation and improving skin tone. This was a follow-up study of another study from 2007 that showed similar results.

One study compared 4% hydroquinone (HQ) to 4% nicotinamide in people with melasma, a condition similar to post-inflammatory hyperpigmentation. 55% of the participants treated with hydroquinone showed good to excellent results vs. 44% of patients treated with nicotinamide. 18% in the HQ group complained of moderate side-effects whereas 7% in the nicotinamide group complained of mild side-effects.

Castanedo-Cazares et al. compared 4% nicotinamide and 0.05% desonide (corticosteroid) on persistent PIH in a colored skin. The desonide group showed slightly better results with 12% showing excellent, 18% good, 31% moderate, and 37% mild response; the corresponding figures in the vitamin B3 group were 12% excellent, 12% good, 43% moderate, 31% mild. In contrast, 90% treated with a placebo showed poor to mild response.


An Egyptian study asked 20 women to apply a 2% liquiritin (a substance found in licorice flavones) cream on one side of the face and a placebo cream on the other side. 80% of the women showed excellent results in the licorice-treated side vs. none in the placebo-treated side.

A Pakistani study from 2009 compared the effectiveness of 4% liquiritin, 2% liquiritin, and 4% hydroquinone on melasma patients. Their results showed that 73.3% of patients treated with hydroquinone improved vs. 96.7% and 86.7% of the patients improved in the 4% and 2% liquiritin groups. The researchers concluded that liquiritin was both more effective and safer than hydroquinone.

Licorice extract is a mixture of many substances. These studies used a part of a single substance found in licorice extracts. Which makes me skeptical that you could get the same results with creams that contain licorice extract.


Two studies have looked at treating PIH with soy extracts. One showed an average reduction of 12% in 14 out of the 16 participants. Another study showed a significantly better reduction with SPF 30 sunscreen containing soy than with the SPF 30 sunscreen alone.


One study showed deoxyarbutin has minor skin lightening effects. Prior to treatment, the participants spent 10 to 20 minutes per day in a tanning bed for seven days. The tanned areas where then treated with 3% deoxyarbutin cream (DA), 4% hydroquinone cream (HQ), or nothing (control). After five weeks 44.6% of the tan remained in the untreated control area vs. 37.3% in the DA treated area and 51.6% in the HQ treated area. Deoxyarbutin accelerated the fading of tan whereas hydroquinone hindered fading.

In another study a 3% deoxyarbutin lotion was tested as a skin lightener and treatment for liver spots in Caucasian and dark skinned participants. The results showed skin lightening in Caucasians but not on the darker skinned participants while the liver spots improved in both groups.

Kojic acid

A split-face study compared a 2% hydroquinone lotion to a 2% kojic acid lotion in patients with melasma, both lotions also contained 5% glycolic acid as penetration enhancer. Both lotions produced a similar reduction in skin pigmentation; the kojic acid lotion was more irritating.

Multi-ingredient cream vs. hydroquinone

A study compared a 4% hydroquinone cream to a multi-ingredient cream. Both the hydroquinone and multi-ingredient creams reduced hyperpigmentation by about 20% over 12 weeks. Both creams caused only mild side-effects.

The multi-ingredient cream was formulated to address the mechanisms behind hyperpigmentation and contained the following ingredients:

  • Tetrahexyldecyl ascorbate (an oil-soluble form of vitamin C)
  • Retinol
  • Linoleic acid
  • Glabridin (licorice extract)
  • Hexylresorcinol
  • Nicotinamide

Licorice extract + belides + emblica vs. hydroquinone

Another study compared 2% HQ to a multi-ingredient cream with 7% licorice extract, belides (from daisies), and emblica (Indian gooseberry). Medical examination showed improvements in 78% of the participants in the multi-ingredient group and 89% in the HQ group. Two people in the multi-ingredient cream group and seven individuals in the HQ cream group complained of mild side-effects.

Kojic acid + emblica + glycolic acid vs. hydroquinone

Yet another multi-ingredient cream was compared to 4% HQ. This time, the cream contained kojic acid, emblica extract, and glycolic acid. The effectiveness of the multi-ingredient formulation was comparable to the HQ cream.

Salicylic acid + ellagic acid vs. hydroquinone

Another comparison study pitted a 4% HQ cream against a cream containing 0.5% ellagic acid and 0.1% salicylic acid. Ellagic acid is a natural antioxidant found in many fruits and vegetables. Both creams were equally effective in reducing hyperpigmentation and dark spots.

About Me

Hi, I am Acne Einstein(a.k.a. Seppo Puusa). I'm a bit of a science nerd who is also passionate about health. I enjoy digging through medical journals for acne treatment gems I can share here. You can read more about my journey through acne and how I eventually ended up creating this.


  • Gonzalez, N. & Perez, M. Natural Cosmeceutical Ingredients for Hyperpigmentation. Journal of drugs in dermatology : JDD 15, 26–34 (2016). https://www.ncbi.nlm.nih.gov/pubmed/26741379
  • Davis, E. C. & Callender, V. D. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol 3, 20–31 (2010). https://www.ncbi.nlm.nih.gov/pubmed/20725554
  • Alexis, A. F. & Blackcloud, P. Natural ingredients for darker skin types: growing options for hyperpigmentation. J Drugs Dermatol 12, s123–7 (2013). https://www.ncbi.nlm.nih.gov/pubmed/24002160
  • Leyden, J. J., Shergill, B., Micali, G., Downie, J. & Wallo, W. Natural options for the management of hyperpigmentation.J Eur Acad Dermatol Venereol 25, 1140–5 (2011). https://www.ncbi.nlm.nih.gov/pubmed/21623927
  • Amer, M. & Metwalli, M. Topical liquiritin improves melasma. Int. J. Dermatol. 39,299–301 (2000). https://www.ncbi.nlm.nih.gov/pubmed/10809983
  • Zubair, S & Mujtaba, G. Comparison of efficacy of topical 2% liquiritin, topical 4% liquiritin and topical 4% hydroquinone in the management of melasma. Journal of Pakistan Association of Dermatologists (2009). https://citeseerx.ist.psu.edu/viewdoc/download?doi=
  • Jerajani, H. R., Mizoguchi, H., Li, J., Whittenbarger, D. J. & Marmor, M. J. The effects of a daily facial lotion containing vitamins B3 and E and provitamin B5 on the facial skin of Indian women: a randomized, double-blind trial. Indian J Dermatol Venereol Leprol 76, 20–6 (2010). https://www.ncbi.nlm.nih.gov/pubmed/20061726
  • Kimball, A. B. et al. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial. Br. J. Dermatol. 162, 435–41 (2010). https://www.ncbi.nlm.nih.gov/pubmed/19845667
  • Bissett, D. L. et al. Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol 6, 20–6 (2007). https://www.ncbi.nlm.nih.gov/pubmed/17348991
  • Hakozaki, T. et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br. J. Dermatol. 147,20–31 (2002). https://www.ncbi.nlm.nih.gov/pubmed/12100180
  • Navarrete-Solís, J. et al. A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma. Dermatol Res Pract 2011, 379173 (2011). https://www.ncbi.nlm.nih.gov/pubmed/21822427
  • Castanedo-Cazares, J. P. et al. Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study. Clin Cosmet Investig Dermatol 6, 29–36 (2013). https://www.ncbi.nlm.nih.gov/pubmed/23355788
  • Gold, M. H., Kircik, L. H., Bucay, V. W., Kiripolsky, M. G. & Biron, J. A. Treatment of facial photodamage using a novel retinol formulation. J Drugs Dermatol 12, 533–40 (2013). https://www.ncbi.nlm.nih.gov/pubmed/23652947
  • Tucker-Samaras, S. et al. A stabilized 0.1% retinol facial moisturizer improves the appearance of photodamaged skin in an eight-week, double-blind, vehicle-controlled study. J Drugs Dermatol 8, 932–6 (2009). https://www.ncbi.nlm.nih.gov/pubmed/19852122
  • Kikuchi, K., Suetake, T., Kumasaka, N. & Tagami, H. Improvement of photoaged facial skin in middle-aged Japanese females by topical retinol (vitamin A alcohol): a vehicle-controlled, double-blind study. J Dermatolog Treat 20, 276–81 (2009). https://www.ncbi.nlm.nih.gov/pubmed/20078381
  • Wallo, W., Nebus, J. & Leyden, J. J. Efficacy of a soy moisturizer in photoaging: a double-blind, vehicle-controlled, 12-week study. J Drugs Dermatol6, 917–22 (2007). https://www.ncbi.nlm.nih.gov/pubmed/17941363
  • Gonzalez R, Cauwenbergh G. Effects of soy on hyperpigmentation in Caucasian and Hispanic populations.Poster presented at: 59th Annual Meeting of the American Academy of Dermatology. March 2-7 , 2001; Washington, DC. Referred via https://www.ncbi.nlm.nih.gov/pubmed/24002160
  • Hamed, S. H. et al. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent. J Cosmet Sci 57,291–308 (2006). https://www.ncbi.nlm.nih.gov/pubmed/16957809
  • Boissy, R. E., Visscher, M. & DeLong, M. A. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp. Dermatol. 14,601–8 (2005). https://www.ncbi.nlm.nih.gov/pubmed/16026582
  • Garcia, A. & Fulton, J. E. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 22, 443–7 (1996). https://www.ncbi.nlm.nih.gov/pubmed/8634807
  • Lim, J. T. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg25, 282–4 (1999). https://www.ncbi.nlm.nih.gov/pubmed/10417583
  • Makino, E. T. et al. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone. J Drugs Dermatol 11, 1478–82 (2012). https://www.ncbi.nlm.nih.gov/pubmed/23377519
  • Draelos, Z. D., Yatskayer, M., Bhushan, P., Pillai, S. & Oresajo, C. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening. Cutis 86, 153–8 (2010). https://www.ncbi.nlm.nih.gov/pubmed/21049734
  • Dahl, A., Yatskayer, M., Raab, S. & Oresajo, C. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone. J Drugs Dermatol 12, 52–8 (2013). https://www.ncbi.nlm.nih.gov/pubmed/23377328
  • Costa, A., Moisés, T. A. A., Cordero, T., Alves, C. R. & Marmirori, J. Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma. An Bras Dermatol85, 613–20 (2010). https://www.ncbi.nlm.nih.gov/pubmed/21152784
  • Choi, Y. K. et al. Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo. Int. J. Dermatol. 49, 218–26 (2010). https://www.ncbi.nlm.nih.gov/pubmed/20465650
  • Espinal-Perez, L. E., Moncada, B. & Castanedo-Cazares, J. P. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int. J. Dermatol. 43, 604–7 (2004). https://www.ncbi.nlm.nih.gov/pubmed/15304189
  • Kameyama, K. et al. Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J. Am. Acad. Dermatol. 34, 29–33 (1996). https://www.ncbi.nlm.nih.gov/pubmed/8543691
  • Farris, P. K. Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. Dermatol Surg 31, 814–7; discussion 818 (2005). https://www.ncbi.nlm.nih.gov/pubmed/16029672
  • Choi, Y. K. et al. Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo. Int. J. Dermatol. 49, 218–26 (2010). https://www.ncbi.nlm.nih.gov/pubmed/24091488
  • Kim, W.-S. S. Efficacy and safety of a new superficial chemical peel using alpha-hydroxy acid, vitamin C and oxygen for melasma. J Cosmet Laser Ther 15, 21–4 (2013). https://www.ncbi.nlm.nih.gov/pubmed/23368684
  • Khemis, A., Cabou, J., Dubois, J. & Ortonne, J. A randomized controlled study to evaluate the depigmenting activity of lascorbic acid plus phytic acid – serum vs. placebo on solar lentigines. J Cosmet Dermatology 10, 266–272 (2011). https://www.ncbi.nlm.nih.gov/pubmed/22151934
  • Ochiai, Y. et al. A new lipophilic pro-vitamin C, tetra-isopalmitoyl ascorbic acid (VC-IP), prevents UV-induced skin pigmentation through its anti-oxidative properties. J. Dermatol. Sci. 44, 37–44 (2006). https://www.ncbi.nlm.nih.gov/pubmed/16935471
  • Herndon, J. H., Jiang, L. I., Kononov, T. & Fox, T. An Open Label Clinical Trial to Evaluate the Efficacy and Tolerance of a Retinol and Vitamin C Facial Regimen in Women With Mild-to-Moderate Hyperpigmentation and Photodamaged Facial Skin. J Drugs Dermatol 15, 476–82 (2016). https://www.ncbi.nlm.nih.gov/pubmed/27050703
  • Hwang, S.-W. W., Oh, D.-J. J., Lee, D., Kim, J.-W. W. & Park, S.-W. W. Clinical efficacy of 25% L-ascorbic acid (C’ensil) in the treatment of melasma. J Cutan Med Surg13, 74–81 (2009). https://www.ncbi.nlm.nih.gov/pubmed/19298775